Uncategorized

RSB Dermatology

HAD COSMETIC FILLERS? YOU CAN GET THE COVID-19 VACCINE!

In rare cases, cosmetic fillers can swell slightly after a vaccine. This has been recently reported with the COVID vaccine. This reaction is temporary and usually resolves within 24-48 hours and can be treated. None of the reported cases were serious, life-threatening, or had long-term complications. For this reason, one who has a history of…

Read More »

RSB Dermatology

FRECKLES

Freckles are brown spots that commonly occur in sun-exposed areas on the skin that are harmless. As one gets sun exposure, the spots darken. When one avoids the sun or UV exposure, the spots lighten. The face is the most common area affected, but the arms and legs are common sites as well. It is…

Read More »

RSB Dermatology

COVID-19 FACTS

The entire world has become affected by Covid-19, formally known as SARS-CoV-2. This virus originated in China. Most current data suggest that this virus, or more likely a predecessor of it, had a bat host. The horseshoe bat has been theorized as one potential host. From there we have several opinions as to what happened….

Read More »

RSB Dermatology

THE ACNE ONE-TWO PUNCH–THE BEST OVER-THE-COUNTER TREATMENT

Finally, patients are able to self-treat mild to moderate inflammatory and comedonal acne with over-the-counter treatments. Blackheads and whiteheads can now be treated effectively with Differin gel, which went over-the-counter earlier this year. This medication is similar to Retin A, the drug everyone knows about. These medications help to unclog pores are and more effective…

Read More »

RSB Dermatology

HYDROCHLOROTHIAZIDE (HCTZ) USE IS ASSOCIATED WITH INCREASED RISK OF BASAL CELL AND SQUAMOUS CELL CARCINOMA

A recent study published in the Journal of the American Academy of Dermatology has shown that taking hydrochlorothiazide (HCTZ) is associated with an increased risk of basal cell carcinoma and an even higher risk of squamous cell carcinoma. The risk was dose dependent (the higher the cumulative dose, the higher the risk). An increased risk…

Read More »

RSB Dermatology

INFECTIONS AFTER A PEDICURE

Patients often ask about the risk of getting infections after a Pedicure. In most cases, they are asking about getting a toenail fungal infection, which is rare in this circumstance. Bacterial infections have occurred after getting a Pedicure, although is uncommon. Those who are immuno-compromised or have diabetes and/or poor circulation are more at risk…

Read More »

RSB Dermatology

I HAVE A SKIN PROBLEM: WHO SHOULD I SEE?

Without question, it is ALWAYS best to see a well-trained, board-certified Dermatologist if one has any skin problems (rashes or growths).  Although many PCPs and Urgent care centers can handle COMMON problems (i.e. Shingles, poison ivy and minor burns), what happens when both you and the doctor does not know what the diagnosis is? In many of these cases, patients…

Read More »

RSB Dermatology

HIGH DEDUCTIBLE: CHOOSE YOUR DERMATOLOGIST WISELY!

Nowadays it is common to have a very high deductible. This is a big problem as patients are bearing a significant cost. In this case, it is very important to choose your doctor wisely!!!  Let me give you a few examples and some critical information. Contracted Rates–some plans pay doctors very differently. In fact, one…

Read More »

RSB Dermatology

NEW DRUGS FOR PSORIASIS LOOKING GREAT!

TYK2 inhibitor is being developed by Bristol-Myers Squibb and the early Phase II trial results have been great. Why? Here is the scientific talk: the TYK2 inhibitor has been shown to be 100 times more selective in inhibiting IL-23 , IL-12, and interferon-alpha than JAK 1/3 inhibitors and 3,000 times more selective than JAK 2 inhibitors. What do you…

Read More »

RSB Dermatology

“BETTER THAN BOTOX?”

Revance Therapeutics Inc. said that an experimental drug RT002 [injectable daxibotulinumtoxinA] can smooth wrinkles for longer than Allergan’s Botox, according to the results of late-stage studies. We will have to wait for the published data to see, but at least early reports look promising.

Read More »

Categories

Subscribe!